Category
Cancer
Sub Category
Lung
Study Name
E2511: Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination with Veliparib (ABT-888) or placebo as Frontline Therapy for Extensive Stage Small Cell Lung Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance